Evaluation of the Apo-1/Fas promoter Mva I polymorphism in multiple sclerosis

Abstract

The pathogenesis of multiple sclerosis is under strong genetic control involving several or more genes each of modest effect. Whilst the mechanisms underlying the pathogenesis of MS remain unknown, it has been hypothesised that either decreased apoptosis of autoreactive T cells in the CNS, or increased apoptosis of oligodendrocytes may play an important role. The Apo-1/Fas antigen (CD95), the gene for which is located in a chromosomal region showing linkage in MS genome screens, is a critical inducer of apoptosis and studies have shown aberrant expression of this molecule in MS, correlating with a decrease in T cell apoptosis or increase in CNS tissue damage. This study investigated an Mva I polymorphism in the Apo-1/Fas promoter region in a group of 124 Australian patients with relapsing-remitting MS and in 183 normal controls. Whilst there were increases in the Mva I*2 allele in MS individuals overall (59% vs 52%, P not corrected=0.08), and in HLA-DRB1*1501 negative MS patients (62% vs 55%), these were not significantly different from controls. Interactions were investigated between the Mva I alleles and T cell receptor beta chain variable region (TCRBV) germline polymorphisms, with a trend in MS individuals towards a decrease of the Mva I*1 allele when combined with the TCRBV3S1*2 allele (Relative Risk=0.25, P=0.067), and with the TCRBV8S1*1 allele (Relative Risk=0.44, P=0.12). Overall, the findings of this study indicate a possible effect of the Apo-1/Fas promoter Mva I polymorphism in MS susceptibility, which needs to be confirmed in further studies.

Keywords

Apo-1/Fas apoptosis autoimmunity genetic susceptibility multiple sclerosis polymorphism

Get full access to this article

View all access options for this article.

References

Ewing C , Bernard CCA. (1998) Insights into the aetiology and pathogenesis of multiple sclerosis . Immunol Cell Biol 76: 47-54 .

Dowling P et al. (1997) Cell death and birth in multiple sclerosis brain . J Neurol Sci 149: 1-11 .

Pender MP. (1998) Genetically determined failure of activation-induced apoptosis of autoreactive T cells as a cause of multiple sclerosis . Lancet 351: 978-981 .

Ware CF , VanArsdale S , VanArsdale TL. (1996) Apoptosis mediated by the TNF-related cytokine and receptor families . J Cell Biochem 60: 47-55 .

Ciusani E et al. (1998) Soluble Fas (Apo-1) levels in cerebrospinal fluid of multiple sclerosis patients . J Neuroimmunol 82: 5-12 .

Zipp F et al. (1998) Serum CD95 of relapsing remitting multiple sclerosis patients protects from CD95-mediated apoptosis . J Neuroimmunol 86: 151-154 .

Dowling P et al. (1996) Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain . J Exp Med 184: 1513-1518 .

D'Souza SD et al. (1996) Multiple sclerosis: Fas signaling in oligodendrocyte cell death . J Exp Med 184: 2361-2370 .

Bonetti B , Raine CS. (1997) Multiple sclerosis: oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis . Ann Neurol 42: 74-84 .

10.

Sadovnick AD et al. (1993) A population-based twin study of multiple sclerosis in twins: update . Ann Neurol 33: 281-285 .

11.

Sadovnick AD , Ebers GC , Dyment DA , Risch NJ. (1996) Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group . Lancet 347: 1728-1730 .

12.

Ebers GC , Sadovnick AD , Risch NJ. (1995) A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group . Nature 377: 150-151 .

13.

Olerup O , Hillert J. (1995) HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation . Tissue Antigens 2: 1-4 .

14.

Stewart GJ et al. (1997) HLA-DR, -DQA1 and -DQB1 associations in Australian multiple sclerosis patients . Eur J Immunogenet 24: 81-92 .

15.

Haines JL et al. (1998) Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The multiple sclerosis genetic group . Hum Mol Genet 7: 1229-1234 .

16.

Sawcer S et al. (1996) A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22 . Nature Genet 13: 464-468 .

17.

Haines JL et al. (1996) A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex . Nature Genet 13: 469-471 .

18.

Ebers GC et al. (1996) A full genomic search in multiple sclerosis . Nature Genet 13: 472-476 .

19.

Kuokkanen S et al. (1997) Genomewide scan of multiple sclerosis in Finnish multiplex families . Am J Hum Genet 61: 1379-1387 .

20.

Bell JI , Lathrop GM. (1996) Multiple loci for multiple sclerosis . Nature Genet 13: 377-378 .

21.

Stewart GJ. (1997) Multiple sclerosis, multiple genes [editorial] . Med J Aust 166: 573-574 .

22.

Dyment DA , Sadnovich AD , Ebers GC. (1997) Genetics of multiple sclerosis . Hum Mol Genet 6: 1693-1698 .

23.

Inazawa J , Itoh N , Abe T , Nagata S. (1992) Assignment of the human Fas antigen (FAS) to 10q24.1 . Genomics 14: 821-822 .

24.

Huang QR , Morris D , Manolios N. (1997) Identification and characterization of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene . Mol Immunol 34: 577-582 .

25.

Poser CM et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols . Ann Neurol 13: 227-231 .

26.

Kurtzke JF. (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) . Neurology 33: 1444-1452 .

27.

Lahiri DK , Nurnberger JI. (1991) A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies . Nucleic Acids Research 19: 5444-5444 .

28.

Tiwari JL , Terasaki PI. (1985) HLA and disease associations. Springer-Verlag: New York .

29.

Huang QR et al. (1999) Evaluation of a new Apo-1/Fas promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus . Rheumatol 38: 645-651 .

30.

Cascino I et al. (1998) Fas gene polymorphisms are not associated with systemic lupus erythematosus, multiple sclerosis and HIV infection . Dis Markers 13: 221-225 .

31.

Chataway J et al. (1998) The genetics of multiple sclerosis: principles, background and updated results of the United Kingdom systematic genome screen . Brain 121: 1869-1887 .

32.

Ihle JN. (1995) Cytokine receptor signalling . Nature 377: 591-594 .

33.

Horwitz MS et al. (1997) Primary demyelination in transgenic mice expressing interferon-gamma . Nat Med 3: 1037-1041 .

34.

Hockertz MK , Paty DW , Beall SS. (1998) Susceptibility to relapsing-progressive multiple sclerosis is associated with inheritance of genes linked to the variable region of the TcR beta locus: use of affected family-based controls . Am J Hum Genet 62: 373-385 .

35.

Kellar-Wood HF et al. (1995) Multiple sclerosis and the HLA-D region: linkage and association studies . JNeuroimmunol 58: 183-190 .

36.

Beall SS et al. (1989) The germline repertoire of T cell receptor b-chain genes in patients with chronic progressive multiple sclerosis . J Neuroimmunol 21: 59-66 .

37.

Martinez-Naves E , Victoria-Gutierrez M , Uria DF , Lopez-Larrea C. (1993) The germline repertoire of T cell b chain genes in multiple sclerosis patients from Spain . J Neuroimmunol 47: 9-14 .